Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Bacterial Infections and Mycoses

  Free Subscription


Articles published in J Infect Dis

Retrieve available abstracts of 152 articles:
HTML format
Text format



Single Articles


    November 2017
  1. GARFIN C, Mantala M, Yadav R, Hanson CL, et al
    Using Patient Pathway Analysis to Design Patient-centered Referral Networks for Diagnosis and Treatment of Tuberculosis: The Case of the Philippines.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  2. HANSON C, Osberg M, Brown J, Durham G, et al
    Finding the Missing Patients With Tuberculosis: Lessons Learned From Patient-Pathway Analyses in 5 Countries.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  3. HANSON CL, Osberg M, Brown J, Durham G, et al
    Conducting Patient-Pathway Analysis to Inform Programming of Tuberculosis Services: Methods.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  4. MASINI E, Hanson C, Ogoro J, Brown J, et al
    Using Patient-Pathway Analysis to Inform a Differentiated Program Response to Tuberculosis: The Case of Kenya.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  5. FATIMA R, Haq MU, Yaqoob A, Mahmood N, et al
    Delivering Patient-Centered Care in a Fragile State: Using Patient-Pathway Analysis to Understand Tuberculosis-Related Care Seeking in Pakistan.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  6. SURYA A, Setyaningsih B, Suryani Nasution H, Gita Parwati C, et al
    Quality Tuberculosis Care in Indonesia: Using Patient Pathway Analysis to Optimize Public-Private Collaboration.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  7. FEKADU L, Hanson C, Osberg M, Makayova J, et al
    Increasing Access to Tuberculosis Services in Ethiopia: Findings From a Patient-Pathway Analysis.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  8. SISMANIDIS C, Shete PB, Lienhardt C, Floyd K, et al
    Harnessing the Power of Data to Guide Local Action and End Tuberculosis.
    J Infect Dis. 2017;216.
    PubMed     Text format    


  9. REID MJA, Goosby E
    Patient-Centered Tuberculosis Programs Are Necessary to End the Epidemic.
    J Infect Dis. 2017;216.
    PubMed     Text format    


  10. CHIN DP, Hanson CL
    Finding the Missing Tuberculosis Patients.
    J Infect Dis. 2017;216.
    PubMed     Text format    


  11. NAIDOO P, Theron G, Rangaka MX, Chihota VN, et al
    The South African Tuberculosis Care Cascade: Estimated Losses and Methodological Challenges.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  12. CHURCHYARD G, Kim P, Shah NS, Rustomjee R, et al
    What We Know About Tuberculosis Transmission: An Overview.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  13. TURNER RD, Chiu C, Churchyard GJ, Esmail H, et al
    Tuberculosis Infectiousness and Host Susceptibility.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  14. MATHEMA B, Andrews JR, Cohen T, Borgdorff MW, et al
    Drivers of Tuberculosis Transmission.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  15. AULD SC, Kasmar AG, Dowdy DW, Mathema B, et al
    Research Roadmap for Tuberculosis Transmission Science: Where Do We Go From Here and How Will We Know When We're There?
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  16. DOWDY DW, Grant AD, Dheda K, Nardell E, et al
    Designing and Evaluating Interventions to Halt the Transmission of Tuberculosis.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  17. SHAH NS, Kim P, Kana BD, Rustomjee R, et al
    Getting to Zero New Tuberculosis Infections: Insights From the National Institutes of Health/US Centers for Disease Control and Prevention/Bill & Melinda Gates Foundation Workshop on Research Needs for Halting Tuberculosis Transmission.
    J Infect Dis. 2017;216.
    PubMed     Text format    


  18. SALVATORE PP, Proano A, Kendall EA, Gilman RH, et al
    Linking individual natural history to population outcomes in tuberculosis.
    J Infect Dis. 2017 Nov 2. doi: 10.1093.
    PubMed     Text format     Abstract available


  19. LIN SM, Jang AY, Zhi Y, Gao S, et al
    Immunization with a Latch Peptide Provides Serotype-Independent Protection against Group B Streptococcus Infection in Mice.
    J Infect Dis. 2017 Nov 2. doi: 10.1093.
    PubMed     Text format     Abstract available


  20. ANDREONI F, Ugolini F, Keller N, Neff A, et al
    Immunoglobulin attenuates streptokinase-mediated virulence in Streptococcus dysgalactiae subsp. equisimilis necrotizing fasciitis.
    J Infect Dis. 2017 Nov 1. doi: 10.1093.
    PubMed     Text format     Abstract available


    October 2017
  21. CHONG KKL, Tay WH, Janela B, Yong AMH, et al
    Enterococcus faecalis modulates immune activation and slows healing during wound infection.
    J Infect Dis. 2017 Oct 17. doi: 10.1093.
    PubMed     Text format     Abstract available


  22. BUNJUN R, Riou C, Soares AP, Thawer N, et al
    Effect of HIV on the frequency and number of Mycobacterium tuberculosis-specific CD4+ T cells in blood and the airways in latent tuberculosis infection.
    J Infect Dis. 2017 Oct 5. doi: 10.1093.
    PubMed     Text format     Abstract available


    September 2017
  23. GOLDMANN O, Beineke A, Medina E
    Identification of a novel subset of myeloid-derived suppressor cells during chronic staphylococcal infection that resembles immature eosinophils.
    J Infect Dis. 2017 Sep 23. doi: 10.1093.
    PubMed     Text format     Abstract available


  24. ROSEN GH, Randis TM, Desai PV, Sapra KJ, et al
    Group B Streptococcus and the Vaginal Microbiota.
    J Infect Dis. 2017;216:744-751.
    PubMed     Text format     Abstract available


  25. ROCKWOOD N, Sirgel F, Streicher E, Warren R, et al
    Low Frequency of Acquired Isoniazid and Rifampicin Resistance in Rifampicin-Susceptible Pulmonary Tuberculosis in a Setting of High HIV-1 Infection and Tuberculosis Coprevalence.
    J Infect Dis. 2017;216:632-640.
    PubMed     Text format     Abstract available


  26. WIDDOWSON MA, Bresee JS, Jernigan DB
    The Global Threat of Animal Influenza Viruses of Zoonotic Concern: Then and Now.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  27. LIU B, Havers FP, Zhou L, Zhong H, et al
    Clusters of Human Infections With Avian Influenza A(H7N9) Virus in China, March 2013 to June 2015.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  28. CHAKRABORTY A, Rahman M, Hossain MJ, Khan SU, et al
    Mild Respiratory Illness Among Young Children Caused by Highly Pathogenic Avian Influenza A (H5N1) Virus Infection in Dhaka, Bangladesh, 2011.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  29. PACHULEC E, Abdelwahed Bagga RB, Chevallier L, O'Donnell H, et al
    Enhanced Macrophage M1 Polarization and Resistance to Apoptosis Enable Resistance to Plague.
    J Infect Dis. 2017;216:761-770.
    PubMed     Text format     Abstract available


  30. SCHLABERG R, Ampofo K, Tardif KD, Stockmann C, et al
    Human Bocavirus Capsid Messenger RNA Detection in Children With Pneumonia.
    J Infect Dis. 2017;216:688-696.
    PubMed     Text format     Abstract available


  31. MADIGAN CA, Cameron J, Ramakrishnan L
    A Zebrafish Model of Mycobacterium leprae Granulomatous Infection.
    J Infect Dis. 2017;216:776-779.
    PubMed     Text format     Abstract available


  32. BRICIO-MORENO L, Ebruke C, Chaguza C, Cornick J, et al
    Comparative genomic analysis and in vivo modelling of Streptococcus pneumoniae ST3081 and ST618 isolates reveal key genetic and phenotypic differences contributing to clonal replacement of serotype 1 in The Gambia.
    J Infect Dis. 2017 Sep 14. doi: 10.1093.
    PubMed     Text format     Abstract available


  33. NEGRI CE, Johnson A, McEntee L, Box H, et al
    Pharmacodynamics of the Novel Antifungal Agent F901318 for Acute Sinopulmonary Aspergillosis Caused by Aspergillus flavus.
    J Infect Dis. 2017 Sep 12. doi: 10.1093.
    PubMed     Text format     Abstract available


  34. STEPHEN-VICTOR E, Karnam A, Fontaine T, Beauvais A, et al
    Aspergillus fumigatus cell wall alpha-(1,3)-glucan stimulates regulatory T cell polarization by inducing PD-L1 expression on human dendritic cells.
    J Infect Dis. 2017 Sep 8. doi: 10.1093.
    PubMed     Text format     Abstract available


  35. YU Q, Cheng Y, Wang Y, Wang C, et al
    Aberrant Humoral Immune Responses in Neurosyphilis: CXCL13/CXCR5 Play a Pivotal Role for B-Cell Recruitment to the Cerebrospinal Fluid.
    J Infect Dis. 2017;216:534-544.
    PubMed     Text format     Abstract available


    August 2017
  36. MEINEL C, Sparta G, Dahse HM, Horhold F, et al
    Streptococcus pneumoniae From Patients With Hemolytic Uremic Syndrome Binds Human Plasminogen via the Surface Protein PspC and Uses Plasmin to Damage Human Endothelial Cells.
    J Infect Dis. 2017 Aug 26. doi: 10.1093.
    PubMed     Text format     Abstract available


  37. OSTROSKY-ZEICHNER L, Andes D
    The Role of In Vitro Susceptibility Testing in the Management of Candida and Aspergillus.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  38. LEWIS RE, Verweij PE
    Animal Models for Studying Triazole Resistance in Aspergillus fumigatus.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  39. CHOWDHARY A, Sharma C, Meis JF
    Azole-Resistant Aspergillosis: Epidemiology, Molecular Mechanisms, and Treatment.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  40. ARENDRUP MC, Patterson TF
    Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  41. MCCARTHY MW, Kontoyiannis DP, Cornely OA, Perfect JR, et al
    Novel Agents and Drug Targets to Meet the Challenges of Resistant Fungi.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  42. MCCARTHY MW, Denning DW, Walsh TJ
    Future Research Priorities in Fungal Resistance.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  43. VAN BEEK J, Veenhoven RH, Bruin JP, van Boxtel RAJ, et al
    Influenza-like Illness Incidence Is Not Reduced by Influenza Vaccination in a Cohort of Older Adults, Despite Effectively Reducing Laboratory-Confirmed Influenza Virus Infections.
    J Infect Dis. 2017;216:415-424.
    PubMed     Text format     Abstract available


  44. SINGH V, Prakhar P, Rajmani RS, Mahadik K, et al
    Histone Methyltransferase SET8 Epigenetically Reprograms Host Immune Responses to Assist Mycobacterial Survival.
    J Infect Dis. 2017;216:477-488.
    PubMed     Text format     Abstract available


  45. NIELSEN TB, Pantapalangkoor P, Luna BM, Bruhn KW, et al
    Monoclonal Antibody Protects Against Acinetobacter baumannii Infection by Enhancing Bacterial Clearance and Evading Sepsis.
    J Infect Dis. 2017;216:489-501.
    PubMed     Text format     Abstract available


  46. DHAWAN SR, Sankhyan N
    Predictors of Mortality in Patients With Tuberculous.
    J Infect Dis. 2017;216:394-395.
    PubMed     Text format    


  47. NEERADI C, Muthu R, Dangeti GV, Soundravally R, et al
    Cerebrospinal Fluid Leukotriene B4 and Soluble Tumor Necrosis Factor Receptor II Levels and Treatment Outcome in Tuberculous Meningitis.
    J Infect Dis. 2017;216:392-394.
    PubMed     Text format    


    July 2017
  48. LEWIS J, Price MJ, Horner PJ, White PJ, et al
    Genital Chlamydia trachomatis Infections Clear More Slowly in Men Than Women, but Are Less Likely to Become Established.
    J Infect Dis. 2017;216:237-244.
    PubMed     Text format     Abstract available


  49. KAM YW, Leite JA, Lum FM, Tan JJL, et al
    Specific Biomarkers Associated With Neurological Complications and Congenital Central Nervous System Abnormalities From Zika Virus-Infected Patients in Brazil.
    J Infect Dis. 2017;216:172-181.
    PubMed     Text format     Abstract available


  50. OGIMI C, Greninger AL, Waghmare AA, Kuypers JM, et al
    Prolonged Shedding of Human Coronavirus in Hematopoietic Cell Transplant Recipients: Risk Factors and Viral Genome Evolution.
    J Infect Dis. 2017;216:203-209.
    PubMed     Text format     Abstract available


  51. GOLDEN MR, Workowski KA, Bolan G
    Developing a Public Health Response to Mycoplasma genitalium.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  52. WIESENFELD HC, Manhart LE
    Mycoplasma genitalium in Women: Current Knowledge and Research Priorities for This Recently Emerged Pathogen.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  53. MCGOWIN CL, Totten PA
    The Unique Microbiology and Molecular Pathogenesis of Mycoplasma genitalium.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  54. MARTIN DH, Manhart LE, Workowski KA
    Mycoplasma genitalium From Basic Science to Public Health: Summary of the Results From a National Institute of Allergy and Infectious Disesases Technical Consultation and Consensus Recommendations for Future Research Priorities.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  55. HORNER PJ, Martin DH
    Mycoplasma genitalium Infection in Men.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  56. BRADSHAW CS, Jensen JS, Waites KB
    New Horizons in Mycoplasma genitalium Treatment.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  57. GAYDOS CA
    Mycoplasma genitalium: Accurate Diagnosis Is Necessary for Adequate Treatment.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  58. MULDERS MN, Serhan F, Goodson JL, Icenogle J, et al
    Expansion of Surveillance for Vaccine-preventable Diseases: Building on the Global Polio Laboratory Network and the Global Measles and Rubella Laboratory Network Platforms.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  59. MOE N, Stenseng IH, Krokstad S, Christensen A, et al
    The Burden of Human Metapneumovirus and Respiratory Syncytial Virus Infections in Hospitalized Norwegian Children.
    J Infect Dis. 2017;216:110-116.
    PubMed     Text format     Abstract available


    June 2017
  60. FOLKVARDSEN DB, Norman A, Andersen AB, Rasmussen EM, et al
    Genomic epidemiology of a major Mycobacterium tuberculosis outbreak: Retrospective cohort study in a low incidence setting using sparse time-series sampling.
    J Infect Dis. 2017 Jun 28. doi: 10.1093.
    PubMed     Text format     Abstract available


  61. TAYLOR SM, Madanitsa M, Thwai KL, Khairallah C, et al
    Minimal impact by antenatal subpatent P. falciparum infections on delivery outcomes in Malawian women: a cohort study.
    J Infect Dis. 2017 Jun 27. doi: 10.1093.
    PubMed     Text format     Abstract available


  62. MAERTENS K, Tran TMP, Hens N, Van Damme P, et al
    Effect of Prepregnancy Pertussis Vaccination in Young Infants.
    J Infect Dis. 2017;215:1855-1861.
    PubMed     Text format     Abstract available


  63. GUPTA S, Cheung L, Pokkali S, Winglee K, et al
    Suppressor Cell-Depleting Immunotherapy With Denileukin Diftitox is an Effective Host-Directed Therapy for Tuberculosis.
    J Infect Dis. 2017;215:1883-1887.
    PubMed     Text format     Abstract available


  64. ZHANG BZ, Cai J, Yu B, Xiong L, et al
    Immunotherapy Targeting Adenosine Synthase A Decreases Severity of Staphylococcus aureus Infection in Mouse Model.
    J Infect Dis. 2017 Jun 13. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2017
  65. YAO Y, Lai R, Afkhami S, Haddadi S, et al
    A novel virus-vectored respiratory mucosal vaccine enhances anti-tuberculosis immunity in a humanized model system.
    J Infect Dis. 2017 May 20. doi: 10.1093.
    PubMed     Text format     Abstract available


  66. JORDAN SJ, Olson KM, Barnes S, Wilson LS, et al
    Lower Levels of Cervicovaginal Tryptophan are Associated with Natural Clearance of Chlamydia in Women.
    J Infect Dis. 2017 May 17. doi: 10.1093.
    PubMed     Text format     Abstract available


  67. ANTHONY RM
    Sputum microscopy and tuberculosis infectiousness.
    J Infect Dis. 2017 May 16. doi: 10.1093.
    PubMed     Text format    


  68. DATTA S, Sherman JM, Tovar MA, Bravard MA, et al
    Sputum microscopy with fluorescein diacetate predicts tuberculosis infectiousness.
    J Infect Dis. 2017 May 16. doi: 10.1093.
    PubMed     Text format     Abstract available


  69. POPOVICH KJ, Snitkin ES, Hota B, Green SJ, et al
    Genomic and Epidemiological Evidence for Community Origins of Hospital-Onset Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
    J Infect Dis. 2017 May 9. doi: 10.1093.
    PubMed     Text format     Abstract available


  70. TRIVEDI S, Uhlemann AC, Herman-Bausier P, Sullivan SB, et al
    The Surface Protein SdrF Mediates Staphylococcus epidermidis Adherence to Keratin.
    J Infect Dis. 2017 May 8. doi: 10.1093.
    PubMed     Text format     Abstract available


    April 2017
  71. BAKSHI R, Gupta K, Jordan SJ, Brown LT, et al
    Immunoglobulin-Based Investigation of Spontaneous Resolution of Chlamydia trachomatis Infection.
    J Infect Dis. 2017 Apr 21. doi: 10.1093.
    PubMed     Text format     Abstract available


  72. THUONG NTT, Heemskerk D, Tram TTB, Thao LTP, et al
    Leukotriene A4 Hydrolase Genotype and HIV Infection Influence Intracerebral Inflammation and Survival From Tuberculous Meningitis.
    J Infect Dis. 2017 Apr 17. doi: 10.1093.
    PubMed     Text format     Abstract available


  73. FAVA VM, Schurr E
    Evaluating the Impact of LTA4H Genotype and Immune Status on Survival From Tuberculous Meningitis.
    J Infect Dis. 2017 Apr 17. doi: 10.1093.
    PubMed     Text format    


  74. VAN LAARHOVEN A, Dian S, Ruesen C, Hayati E, et al
    Clinical Parameters, Routine Inflammatory Markers, and LTA4H Genotype as Predictors of Mortality Among 608 Patients With Tuberculous Meningitis in Indonesia.
    J Infect Dis. 2017 Apr 17. doi: 10.1093.
    PubMed     Text format     Abstract available


  75. FLORES AR, Luna RA, Runge JK, Shelburne SA 3rd, et al
    Cluster of fatal group A streptococcal emm87 infection within a single family: molecular basis for invasion and transmission.
    J Infect Dis. 2017 Apr 5. doi: 10.1093.
    PubMed     Text format     Abstract available


  76. LEE YJ, Arguello ES, Jenq RR, Littmann E, et al
    Protective Factors in the Intestinal Microbiome Against Clostridium difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation.
    J Infect Dis. 2017;215:1117-1123.
    PubMed     Text format     Abstract available


    March 2017
  77. HAKANSSON AP, Bergenfelz C
    Low NF-kB activation and necroptosis in alveolar macrophages: A new virulence property of Streptococcus pneumoniae.
    J Infect Dis. 2017 Mar 25. doi: 10.1093.
    PubMed     Text format    


  78. SUCHLAND RJ, Dimond ZE, Putman TE, Rockey DD, et al
    Whole-genome sequencing of repeat-positive, same-serovar Chlamydia trachomatis collected from the female genital tract demonstrate persistent infections and genome stability.
    J Infect Dis. 2017 Mar 23. doi: 10.1093.
    PubMed     Text format     Abstract available


  79. ZAPOTOCZNA M, Forde E, Hogan S, Humphreys H, et al
    Eradication of Staphylococcus aureus Biofilm Infections Using Synthetic Antimicrobial Peptides.
    J Infect Dis. 2017;215:975-983.
    PubMed     Text format     Abstract available


  80. SINGH P, Verma D, Backstedt BT, Kaur S, et al
    Borrelia burgdorferi BBI39 Paralogs, Targets of Protective Immunity, Reduce Pathogen Persistence Either in Hosts or in the Vector.
    J Infect Dis. 2017;215:1000-1009.
    PubMed     Text format     Abstract available


  81. SANCHEZ-ENCINALES V, Alvarez-Marin R, Pachon-Ibanez ME, Fernandez-Cuenca F, et al
    Overproduction of Outer Membrane Protein A by Acinetobacter baumannii as a Risk Factor for Nosocomial Pneumonia, Bacteremia, and Mortality Rate Increase.
    J Infect Dis. 2017;215:966-974.
    PubMed     Text format     Abstract available


  82. SZABO PA, Rudak PT, Choi J, Xu SX, et al
    Invariant Natural Killer T Cells Are Pathogenic in the HLA-DR4-Transgenic Humanized Mouse Model of Toxic Shock Syndrome and Can Be Targeted to Reduce Morbidity.
    J Infect Dis. 2017;215:824-829.
    PubMed     Text format     Abstract available


  83. AZARIAN T, Grant LR, Georgieva M, Hammitt LL, et al
    Association of Pneumococcal Protein Antigen Serology With Age and Antigenic Profile of Colonizing Isolates.
    J Infect Dis. 2017;215:713-722.
    PubMed     Text format     Abstract available


    February 2017
  84. HALLIDAY A, Whitworth H, Hermagild Kottoor S, Niazi U, et al
    Stratification of latent tuberculosis infection by cellular immune profiling.
    J Infect Dis. 2017 Feb 28. doi: 10.1093.
    PubMed     Text format     Abstract available


  85. RAY SM
    Preventing Methicillin-Resistant Staphylococcus aureus (MRSA) Disease in Urban US Hospitals-Now for the Hard Part: More Evidence Pointing to the Community as the Source of MRSA Acquisition.
    J Infect Dis. 2017 Feb 22. doi: 10.1093.
    PubMed     Text format    


  86. KARAUZUM H, Haudenschild CC, Moore IN, Mahmoudieh M, et al
    Vaccination induces CD4 T cell-mediated mortality during Staphylococcus aureus bacteremia.
    J Infect Dis. 2017 Feb 21. doi: 10.1093.
    PubMed     Text format     Abstract available


  87. MURRAY GL, Tsyganov K, Kostoulias XP, Bulach DM, et al
    Global Gene Expression Profile of Acinetobacter baumannii During Bacteremia.
    J Infect Dis. 2017;215.
    PubMed     Text format     Abstract available


  88. PARKER D
    Impact of Type I and III Interferons on Respiratory Superinfections Due to Multidrug-Resistant Pathogens.
    J Infect Dis. 2017;215.
    PubMed     Text format     Abstract available


  89. PLANET PJ
    Life After USA300: The Rise and Fall of a Superbug.
    J Infect Dis. 2017;215.
    PubMed     Text format     Abstract available


  90. AHN D, Prince A
    Host-Pathogen Interface: Progress in Understanding the Pathogenesis of Infection Due to Multidrug-Resistant Bacteria in the Intensive Care Unit.
    J Infect Dis. 2017;215.
    PubMed     Text format     Abstract available


  91. GEISINGER E, Isberg RR
    Interplay Between Antibiotic Resistance and Virulence During Disease Promoted by Multidrug-Resistant Bacteria.
    J Infect Dis. 2017;215.
    PubMed     Text format     Abstract available


  92. GOMEZ-SIMMONDS A, Uhlemann AC
    Clinical Implications of Genomic Adaptation and Evolution of Carbapenem-Resistant Klebsiella pneumoniae.
    J Infect Dis. 2017;215.
    PubMed     Text format     Abstract available


  93. JUAN C, Pena C, Oliver A
    Host and Pathogen Biomarkers for Severe Pseudomonas aeruginosa Infections.
    J Infect Dis. 2017;215.
    PubMed     Text format     Abstract available


  94. LOGAN LK, Weinstein RA
    The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace.
    J Infect Dis. 2017;215.
    PubMed     Text format     Abstract available


  95. WEN YC, Hsiao FY, Chan KA, Lin ZF, et al
    Acute Respiratory Infection and Use of Nonsteroidal Anti-Inflammatory Drugs on Risk of Acute Myocardial Infarction: A Nationwide Case-Crossover Study.
    J Infect Dis. 2017;215:503-509.
    PubMed     Text format     Abstract available


  96. BASHA S, Kaur R, Mosmann TR, Pichichero ME, et al
    Reduced Th17 responses to Streptococcus pneumoniae in infection-prone children can be rescued by addition of innate cytokines.
    J Infect Dis. 2017 Feb 13. doi: 10.1093.
    PubMed     Text format    


  97. THOMSEN IP, Sapparapu G, James DB, Cassat JE, et al
    Monoclonal antibodies against the Staphylococcus aureus bicomponent leukotoxin AB (LukAB) isolated following invasive human infection reveal diverse binding and modes of action.
    J Infect Dis. 2017 Feb 10. doi: 10.1093.
    PubMed     Text format    


  98. DZANIBE S, Adrian PV, Mlacha SZ, Dangor Z, et al
    Reduced Transplacental Transfer of Group B Streptococcus Surface Protein Antibodies in HIV-infected Mother-Newborn Dyads.
    J Infect Dis. 2017 Feb 9. doi: 10.1093.
    PubMed     Text format    


  99. ZAPOTOCZNA M, Forde E, Hogan S, Humphreys H, et al
    Eradication of Staphylococcus aureus biofilm infections using synthetic antimicrobial peptides.
    J Infect Dis. 2017 Feb 7. doi: 10.1093.
    PubMed     Text format    


    January 2017
  100. LOFGREN S, Hullsiek KH, Morawski BM, Nabeta HW, et al
    Differences in Immunologic Factors Among Patients Presenting with Altered Mental Status During Cryptococcal Meningitis.
    J Infect Dis. 2017 Jan 30. doi: 10.1093.
    PubMed     Text format     Abstract available


  101. CLARK S, Lanni F, Marinova D, Rayner E, et al
    Revaccination of Guinea Pigs With the Live Attenuated Mycobacterium tuberculosis Vaccine MTBVAC Improves BCG's Protection Against Tuberculosis.
    J Infect Dis. 2017 Jan 25. doi: 10.1093.
    PubMed     Text format     Abstract available


  102. JANSSEN S, Schutz C, Ward AM, Huson MA, et al
    Hemostatic Changes Associated With Increased Mortality Rates in Hospitalized Patients With HIV-Associated Tuberculosis: A Prospective Cohort Study.
    J Infect Dis. 2017;215:247-258.
    PubMed     Text format     Abstract available


  103. WATERS EM, Rudkin JK, Coughlan S, Clair GC, et al
    Redeploying beta-Lactam Antibiotics as a Novel Antivirulence Strategy for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections.
    J Infect Dis. 2017;215:80-87.
    PubMed     Text format     Abstract available


  104. BAYER AS, Xiong YQ
    Redeploying beta-Lactams Against Staphylococcus aureus: Repurposing With a Purpose.
    J Infect Dis. 2017;215:11-13.
    PubMed     Text format    


  105. JESUDOSS CHELLADURAI J, Murphy K, Snobl T, Bader C, et al
    Molecular Epidemiology of Ascaris Infection Among Pigs in Iowa.
    J Infect Dis. 2017;215:131-138.
    PubMed     Text format     Abstract available


  106. HOBBS CV, Anderson C, Neal J, Sahu T, et al
    Trimethoprim-Sulfamethoxazole Prophylaxis During Live Malaria Sporozoite Immunization Induces Long-Lived, Homologous, and Heterologous Protective Immunity Against Sporozoite Challenge.
    J Infect Dis. 2017;215:122-130.
    PubMed     Text format     Abstract available


  107. HER Z, Kam YW, Gan VC, Lee B, et al
    Severity of Plasma Leakage Is Associated With High Levels of Interferon gamma-Inducible Protein 10, Hepatocyte Growth Factor, Matrix Metalloproteinase 2 (MMP-2), and MMP-9 During Dengue Virus Infection.
    J Infect Dis. 2017;215:42-51.
    PubMed     Text format     Abstract available


    December 2016
  108. WANG X, Fan X, Bi S, Li N, et al
    Toll-like Receptor 2-and 4-Mediated Reciprocal Th17 and Antibody Responses to Group A Streptococcus Infection.
    J Infect Dis. 2016 Dec 23. pii: jiw598. doi: 10.1093.
    PubMed     Text format     Abstract available


  109. SULLIVAN MJ, Leclercq SY, Ipe DS, Carey AJ, et al
    The Streptococcus agalactiae virulence regulator CovR affects the pathogenesis of urinary tract infection.
    J Infect Dis. 2016 Dec 23. pii: jiw589. doi: 10.1093.
    PubMed     Text format     Abstract available


  110. SAMPEDRO GR, Bubeck Wardenburg J
    Staphylococcus aureus in the ICU: are these golden grapes ripe for a new approach?
    J Infect Dis. 2016 Dec 21. pii: jiw581. doi: 10.1093.
    PubMed     Text format     Abstract available


  111. PEREZ K, Patel R
    Staphylococcus epidermidis Small-Colony Variants Are Induced by Low pH and Their Frequency Reduced by Lysosomal Alkalinization.
    J Infect Dis. 2016.
    PubMed     Text format    


  112. MARAIS S, Lai RP, Wilkinson KA, Meintjes G, et al
    Inflammasome activation underlies central nervous system deterioration in HIV-associated tuberculosis.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  113. THUONG NT, Thwaites GE
    Treatment associated inflammatory deterioration in tuberculous meningitis: unpicking the paradox.
    J Infect Dis. 2016.
    PubMed     Text format    


  114. GEORGE Z, Omosun Y, Azenabor AA, Partin J, et al
    The roles of unfolded protein response pathways in Chlamydia pathogenesis.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  115. DZANIBE S, Adrian PV, Kimaro Mlacha SZ, Dangor Z, et al
    Reduced trans-placental transfer of group B Streptococcus surface protein antibodies in HIV-infected mother-newborn dyads.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    November 2016
  116. PLANET PJ, Diaz L, Rios R, Arias CA, et al
    Global Spread of the Community-Associated Methicillin-Resistant Staphylococcus aureus USA300 Latin American Variant.
    J Infect Dis. 2016;214:1609-1610.
    PubMed     Text format    


    October 2016
  117. RIBES S, Nessler S, Heide EC, Malzahn D, et al
    The early adaptive immune response in the pathophysiology of pneumococcal meningitis.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  118. BAISTROCCHI SR, Lee MJ, Lehoux M, Ralph B, et al
    Posaconazole-loaded leukocytes as a novel treatment strategy targeting invasive pulmonary aspergillosis.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  119. RUSSELL AN, Zheng X, O'Connell CM, Wiesenfeld HC, et al
    Identification of Chlamydia trachomatis antigens recognized by T cells from highly exposed women who limit or resist genital tract infection.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  120. LATRONICO F, Nasser W, Puhakainen K, Ollgren J, et al
    Genomic tracks behind spread of bacteremic Group A Streptococcus type emm89 in Finland, 2004-2014.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  121. JEYANATHAN M, Damjanovic D, Yao Y, Bramson J, et al
    Induction of an immune protective T cell repertoire with diverse genetic coverage by a novel viral-vectored tuberculosis vaccine in man.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    September 2016
  122. UHLMANN J, Siemens N, Kai-Larsen Y, Fiedler T, et al
    Phosphoglycerate kinase - a novel streptococcal factor involved in neutrophil activation and degranulation.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  123. YU KO, Randolph AG, Agan AA, Yip WK, et al
    Staphylococcus aureus alpha-toxin Response Distinguishes Respiratory Virus-MRSA Co-infection in Children.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  124. NURJADI D, Kain M, Marcinek P, Gaile M, et al
    The ratio of Th1 to Th17 cytokines in whole blood is associated with human beta-defensin-3 expression in skin and persistent Staphylococcus aureus nasal carriage.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  125. PRINCE A, Wang H, Kitur K, Parker D, et al
    Humanized mice exhibit increased susceptibility to Staphylococcus aureus pneumonia.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  126. RASIGADE JP, Dunyach-Remy C, Sapin A, Messad N, et al
    A prophage in diabetic foot ulcer-colonizing Staphylococcus aureus impairs invasiveness by limiting intracellular growth.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  127. MARTINEZ N, Ketheesan N, West K, Vallerskog T, et al
    Impaired Recognition of Mycobacterium tuberculosis by Alveolar Macrophages from Diabetic Mice.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    August 2016
  128. LI L, Cheung A, Bayer AS, Chen L, et al
    The Global Regulon sarA Regulates beta-lactam Antibiotic Resistance In Methicillin-resistant Staphylococcus aureus (MRSA) In Vitro and In Endovascular Infections.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  129. LEWNARD JA, Huppert A, Givon-Lavi N, Pettigrew MM, et al
    Density, serotype diversity, and fitness of Streptococcus pneumoniae in upper respiratory co-colonization with nontypeable Haemophilus influenzae.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  130. SCHLUGER NW
    Host-pathogen interactions in tuberculosis: the evolving story.
    J Infect Dis. 2016.
    PubMed     Text format    


  131. WALTER ND, de Jong BC, Garcia BJ, Dolganov GM, et al
    Adaptation of M. tuberculosis to impaired host immunity in HIV-infected patients.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  132. CHEN L, Zhang J, Zhang H
    Heteroresistance of Mycobacterium tuberculosis strains may be associated more strongly with poor treatment outcomes than within-host heterogeneity of M. tuberculosis infection.
    J Infect Dis. 2016.
    PubMed     Text format    


  133. HORNE DJ, Graustein AD, Shah JA, Peterson G, et al
    Human ULK1 Variation and Susceptibility to Mycobacterium tuberculosis Infection.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  134. DINARDO AR, Mace EM, Lesteberg K, Cirillo JD, et al
    Schistosome Soluble Egg Antigen Decreases Mycobacterium tuberculosis-Specific CD4+ T-Cell Effector Function With Concomitant Arrest of Macrophage Phago-Lysosome Maturation.
    J Infect Dis. 2016;214:479-88.
    PubMed     Text format     Abstract available


  135. AHSAN F, Moura-Alves P, Guhlich-Bornhof U, Klemm M, et al
    Role of Interleukin 36gamma in Host Defense Against Tuberculosis.
    J Infect Dis. 2016;214:464-74.
    PubMed     Text format     Abstract available


    July 2016
  136. DIEDRICH CR, O'Hern J, Gutierrez MG, Allie N, et al
    Relationship between HIV-1 co-infection, IL-10, and M. tuberculosis in human lymph node granulomas.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  137. KRISHNAN S, Chang AC, Stoltz BM, Prasadarao NV, et al
    Escherichia coli K1 modulates peroxisome proliferator-activated receptor-gamma and glucose transporter-1 at the blood-brain barrier in neonatal meningitis.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  138. DOSTER RS, Kirk L, Tetz LM, Rogers LM, et al
    Staphylococcus aureus infection of human gestational membranes induces bacterial biofilm formation and host production of cytokines.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  139. UCHIYAMA S, Keller N, Schlaepfer E, Grube C, et al
    Interferon alpha-Enhanced Clearance of Group A Streptococcus Despite Neutropenia.
    J Infect Dis. 2016;214:321-8.
    PubMed     Text format     Abstract available


  140. YANG HJ, Kong Y, Cheng Y, Janagama H, et al
    Real-Time Imaging of Mycobacterium tuberculosis Using a Novel Near-Infrared Fluorescent Substrate.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  141. RIBES S, Abdullah MR, Saleh M, Hanisch UK, et al
    Thioredoxins and methionine sulfoxide reductases in the pathophysiology of pneumococcal meningitis.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    June 2016
  142. AZARIAN T, Daum RS, Petty LA, Steinbeck JL, et al
    Intra-host evolution of methicillin-resistant Staphylococcus aureus USA300 among individuals with reoccurring skin and soft tissue infections.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  143. PRICE MJ, Ades AE, Welton NJ, Simms I, et al
    Proportion of Pelvic Inflammatory Disease Cases Caused by Chlamydia trachomatis: Consistent Picture From Different Methods.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    May 2016
  144. ANDREONI F, Zurcher C, Tarnutzer A, Schilcher K, et al
    Clindamycin Affects Group A Streptococcus Virulence Factors and Improves Clinical Outcome.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  145. SCRIBA TJ, Kaufmann SH, Lambert PH, Sanicas M, et al
    Vaccination against tuberculosis with whole cell mycobacterial vaccines.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  146. FAN Y, Barash JR, Lou J, Conrad F, et al
    Immunological Characterization and Neutralizing Ability of Monoclonal Antibodies Directed Against Botulinum Neurotoxin Type H.
    J Infect Dis. 2016;213:1606-14.
    PubMed     Text format     Abstract available


  147. SALO J, Pietikainen A, Soderstrom M, Auvinen K, et al
    Flow-Tolerant Adhesion of a Bacterial Pathogen to Human Endothelial Cells Through Interaction With Biglycan.
    J Infect Dis. 2016;213:1623-31.
    PubMed     Text format     Abstract available


  148. SHEPELKOVA G, Evstifeev V, Majorov K, Bocharova I, et al
    Therapeutic effect of recombinant mutated IL-11 in the mouse model of tuberculosis.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  149. XU H, Sobue T, Bertolini M, Thompson A, et al
    Streptococcus oralis and Candida albicans synergistically activate mu-Calpain to degrade E-cadherin from oral epithelial junctions.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    April 2016
  150. PRADOS-ROSALES R, Carreno LJ, Weinrick B, Batista-Gonzalez A, et al
    The Type of Growth Medium Affects the Presence of a Mycobacterial Capsule and Is Associated With Differences in Protective Efficacy of BCG Vaccination Against Mycobacterium tuberculosis.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    January 2016
  151. KOBAYASHI SD, Porter AR, Dorward DW, Brinkworth AJ, et al
    Phagocytosis and killing of carbapenem-resistant ST258 Klebsiella pneumoniae by human neutrophils.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    December 2015
  152. ZHENG D, Yu Y, Li M, Wang G, et al
    Inhibition of miR-195 prevents apoptosis and multiple-organ injury in mouse models of sepsis.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bacterial Infections and Mycoses is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: